TP53INP1 and breast carcinoma: These results suggested that TP53INP1 inhibits hypoxia‐induced downstream effectors that promote EMT and VM formation in a hypoxic microenvironment, and TP53INP1 may be mediated by HIF‐1α in breast cancer cells.